Q8 (R2) Step 5 Pharmaceutical Development
This guideline is intended to provide guidance on the contents of Section 3.2.P.2 (Pharmaceutical Development) for drug products as defined in the scope of Module 3 of the Common Technical Document (ICH guideline M4). The guideline does not apply to contents of submissions for drug products during the clinical research stages of drug development.
Download Q8 (R2) Step 5 Pharmaceutical Development
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
TURKISH MEDICINES AND MEDICAL DEVICES AGENCY …
titck.gov.trNr:663 and Regulation on the Registration Medicinal Products for Human Use published in the Official Gazette Nr:25705 dated January 19, 2005, referring to the Ministerial Consent Nr: 2165621 dated April 13, 2016. Definitions ARTICLE 4 – (1) Following terms used in this Guideline shall have the meaning expressly designated to them below;
Guideline on the use of the CTD format in the preparation ...
www.ema.europa.eugeneral the CTD format should be used in applications for traditional use registration. 2. Scope . This guideline is applicable to applications for traditional use registration of THMPs for human use. The compilation of dossiers for marketing authorisation applications for herbal medicinal products (HMPs) is not covered by this guideline.
Guideline for medical assistance - Department of Housing ...
www.hpw.qld.gov.auQuality use of medicines is one of the objectives of Australia’s National Medicines Policy. While medications make a significant contribution to preventing and treating disease, increasing life expectancy and improving quality of life, they also have the potential to cause harm. Quality use of medicines aims to maximise the
Medication Management Guideline for Registered Nurses ...
www.hse.iecontains a list of medicines which routinely is stocked in the CAH. Emergency Trolley List – contains a list of the medicines stocked on the emergency trolley. The National CAH Requisition Form when completed is approved by the GP onsite 4.1. Guidelines for Pharmacy Stock Check 1.